Cargando…

Correction to: Role of Bempedoic Acid in Clinical Practice

Detalles Bibliográficos
Autores principales:	Ballantyne, Christie M., Bays, Harold, Catapano, Alberico L., Goldberg, Anne, Ray, Kausik K., Saseen, Joseph J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266693/ https://www.ncbi.nlm.nih.gov/pubmed/33871715 http://dx.doi.org/10.1007/s10557-021-07188-w

Ejemplares similares

Role of Bempedoic Acid in Clinical Practice
por: Ballantyne, Christie M., et al.
Publicado: (2021)

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
por: Ballantyne, Christie M., et al.
Publicado: (2022)

New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
por: Pirillo, Angela, et al.
Publicado: (2022)

Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular disease
por: Gunn, Laura H., et al.
Publicado: (2022)

Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
por: Leiter, Lawrence A., et al.
Publicado: (2022)

Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
por: Banach, Maciej, et al.
Publicado: (2020)

Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase
por: Bilen, Ozlem, et al.
Publicado: (2016)

Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis
por: Tummala, Ramyashree, et al.
Publicado: (2022)

Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins
por: Bays, Harold E., et al.
Publicado: (2021)

Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations
por: Orringer, Carl E., et al.
Publicado: (2020)

Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
por: Agarwala, Anandita, et al.
Publicado: (2021)

Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose–response model
por: Jadhav, Satyawan B, et al.
Publicado: (2021)

Bempedoic acid for the treatment of dyslipidemia
por: Marrs, Joel C, et al.
Publicado: (2020)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

Severe Hypertriglyceridemia After Use of Bempedoic Acid
por: Bovy, Valentin, et al.
Publicado: (2023)

THU584 Comparison Of The Cardiovascular Benefits Of Bempedoic Acid With Statins- Analysis By The Cholesterol Treatment Trialists’ Methodology
por: Lincoff, A Michael, et al.
Publicado: (2023)

Bempedoic acid: what prospective uses?
por: Jacomelli, Ilaria, et al.
Publicado: (2023)

Pharmacokinetics of bempedoic acid in patients with renal impairment
por: Amore, Benny M., et al.
Publicado: (2021)

An Update on New Cholesterol Inhibitor: Bempedoic Acid
por: Kulshreshtha, Mayank
Publicado: (2022)

Correction: Prevalence of the Prescription of Potentially Interacting Drugs
por: Tragni, Elena, et al.
Publicado: (2013)

Bempedoic Acid for Lipid Management in the Indian Population: An Expert Opinion
por: Hiremath, Jagdish, et al.
Publicado: (2023)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019)

Bempedoic acid: A nonstatin drug for the management of hypercholesterolemia
por: Govindaraju, Asvitha, et al.
Publicado: (2021)

New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients
por: Toplak, Hermann, et al.
Publicado: (2023)

Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation
por: Linnenberger, Rebecca, et al.
Publicado: (2021)

Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome
por: Biolo, Gianni, et al.
Publicado: (2022)

Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins
por: McQueen, R. Brett, et al.
Publicado: (2022)

Beneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice
por: Hallows, Kenneth R., et al.
Publicado: (2022)

Effects of Bempedoic Acid in Acute Myocardial Infarction in Rats: No Cardioprotection and No Hidden Cardiotoxicity
por: Gergely, Tamás G., et al.
Publicado: (2023)

Bempedoic Acid: An Emerging Therapy for Uncontrolled Low-Density Lipoprotein (LDL) Cholesterol
por: Pradhan, Akshyaya, et al.
Publicado: (2023)

Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies
por: Bays, Harold E., et al.
Publicado: (2013)

Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis
por: Cicero, Arrigo F. G., et al.
Publicado: (2020)

KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid
por: Velázquez, Ana Magdalena, et al.
Publicado: (2022)

Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study
por: Ballantyne, Christie M., et al.
Publicado: (2019)

CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?
por: Jia, Xiaoming, et al.
Publicado: (2019)

Bempedoic Acid: The New Kid on the Block for the Treatment of Dyslipidemia and LDL Cholesterol: A Narrative Review
por: Alam, Uazman, et al.
Publicado: (2021)

Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
por: Ferri, Nicola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ngvhgn6eboks1qefvr6lum6t16